Biosign enters into investor relations agreement with Genoa Capital Markets Counsel



    TORONTO, Sept. 17 /CNW/ - Biosign Technologies Inc. (the "Company") (CNQ:
BIOS) is pleased to announce that it has engaged Genoa Management Limited
("Genoa") to provide the Company with investor relations services.
    The agreement provides that for a six month period commencing on July 1,
2007, the effective date of the agreement, Genoa will provide the Company a
full range of investor relations services. The Company will pay Genoa a
monthly fee plus approved expenses and has granted Genoa a 36-month option
(the "Option") to purchase a total of up to 300,000 common shares of the
Company in three blocks of 100,000 at prices of a $1.60, $2.00 and $2.50 per
common share. The Option shall vest over a 12 month period in increments of
25% on the third month, sixth month, ninth month, and twelfth month
anniversary from the effective date of the agreement. The Company may, at its
sole discretion, reduce the level of services provided by Genoa after the
initial six-month period. In the event that the services are reduced, the
Agreement contains provisions whereby the unvested options would be cancelled.

    About Genoa

    Established in 1999, Genoa provides Canadian listed companies with
independent capital markets counsel as well as financial communications
management and targeted investor outreach support.

    About Biosign

    Biosign develops technologies, products and initiatives to address
critical problems in global health care. The company is committed to becoming
the "world's health monitor" with a robust, integrated and portable system
that provides valuable information for all parties concerned - patients,
physicians, pharmacists, payors and pharmaceutical companies - and a wide
range of potential revenue-generating services. Biosign's breakthrough
technology and continued innovation serve the company's mission to make health
care safe, simple, and sensible.

    %SEDAR: 00014068E




For further information:

For further information: Media inquiries, Hogarth Communications, Don
Hogarth, Phone: (416) 565-8920, Email: don@hogarthpr.com; Investor Relation
inquiries, Genoa Management Limited, Ali Mahdavi, Phone: (416) 962-3300 ext.
225, Email: amahdavi@genoa.ca

Organization Profile

Biosign Technologies Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890